AOM
Research type
Research Study
Full title
Assessment of Viral and Bacterial Pathogens in Young Children Diagnosed with Acute Otitis Media in Primary Care in the United Kingdom
IRAS ID
292852
Contact name
Nick Jacobsen
Contact email
Sponsor organisation
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Duration of Study in the UK
2 years, 0 months, 1 days
Research summary
This study is looking at the viruses and bacteria that are currently causing airway and ear infections, including resistant infections. It will focus on children aged Children ≥3 months to ≤6 years of age in the UK and will take place over a period of two years (March 2021 through to March 2023), with participating General Practitioner (GP) practices across the UK. \nFor those participating, a nasopharyngeal swab will be taken from all children participating in the study. The doctor will gently insert a flexible swab with a soft tip into the child’s nostril. The doctor will guide the swab to the back of the nose and rotate it a few times to collect secretions. If a child presents with pus from the middle ear, a little bit of this ear fluid will be collected from the ear opening with a flexible swab.\nThe nasopharyngeal swab and ear fluid swab (if applicable) is used to do analyses for this study. The samples will be tested to determine which viruses and bacteria are present\n\nThis research may help with understanding how many infections are preventable by vaccination and with creating new guidelines for vaccination and treatment. \n
REC name
North West - Liverpool Central Research Ethics Committee
REC reference
21/NW/0028
Date of REC Opinion
17 Mar 2021
REC opinion
Further Information Favourable Opinion